N-(3-Ooxazol-5-yl)phenyl)-2-(pyrrolidin-3-yl)acetamide hydrochloride, 25mg

S-(2-(N-((4-Amino-2-methylpyrimidin-5-yl)methyl)formamido)-5-(phosphonooxy)pent-2-en-3-yl)benzothioa, 95.0%, 100g

5-Methoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tosyl-1H-pyrrolo[2,3-b]pyridine, 98%, 100mg

Feuille de platine 99,9% 0,025 x 25 x 25 mm 1 pièce

(Pyridin-2-ylmethylene)bis(4,1-phenylene) diacetate, 95.0%, 100g

2-(3-Oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)acetic acid, 95.0%, 100mg

5-Bromo-2,4-dimethoxypyrimidine, 97.0%, 5g

2-(3-Methyl-2,6-dioxo-1,2,3,6-tetrahydro-7h-purin-7-yl)acetic acid, 97%, 100mg

(Z)-1-(2-HYDROXYPHENYL)ETHANONE O-ACETYL OXIME, 95.0%, 2g

3-(3-Fluoro-4-methoxyphenyl)propanoic acid, 95.0%, 1g

2,4-Dibromo-6-chloroaniline, 98%, 25g

Feuille d'indium 99,99% 1 x 100 x 200 mm 1 pièce

[1,3-Bis(diphenylphosphino)propane]nickel(II) Dichloride>98.0%(T)25g